A detailed history of Pro Share Advisors LLC transactions in Savara Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 31,531 shares of SVRA stock, worth $104,367. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,531
Previous 20,630 52.84%
Holding current value
$104,367
Previous $83,000 60.24%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.96 - $5.07 $43,167 - $55,268
10,901 Added 52.84%
31,531 $133,000
Q2 2024

Aug 13, 2024

SELL
$3.66 - $5.34 $18,611 - $27,153
-5,085 Reduced 19.77%
20,630 $83,000
Q1 2024

May 08, 2024

BUY
$4.19 - $5.59 $8,857 - $11,817
2,114 Added 8.96%
25,715 $128,000
Q4 2023

Feb 14, 2024

BUY
$3.18 - $4.9 $37,730 - $58,138
11,865 Added 101.1%
23,601 $110,000
Q3 2023

Nov 13, 2023

BUY
$2.97 - $3.88 $34,855 - $45,535
11,736 New
11,736 $44,000
Q2 2021

Aug 13, 2021

SELL
$1.51 - $2.29 $19,377 - $29,387
-12,833 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$1.17 - $2.33 $2,531 - $5,042
2,164 Added 20.28%
12,833 $27,000
Q4 2020

Feb 09, 2021

BUY
$1.0 - $1.47 $10,669 - $15,683
10,669 New
10,669 $12,000
Q4 2019

Feb 12, 2020

SELL
$0.71 - $4.91 $10,725 - $74,170
-15,106 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$2.16 - $3.2 $2,250 - $3,334
1,042 Added 7.41%
15,106 $40,000
Q2 2019

Aug 13, 2019

SELL
$2.37 - $11.7 $2,332 - $11,512
-984 Reduced 6.54%
14,064 $33,000
Q1 2019

May 15, 2019

BUY
$6.71 - $8.6 $818 - $1,049
122 Added 0.82%
15,048 $111,000
Q4 2018

Feb 14, 2019

SELL
$6.27 - $10.92 $18,120 - $31,558
-2,890 Reduced 16.22%
14,926 $113,000
Q3 2018

Nov 14, 2018

BUY
$10.49 - $12.87 $17,434 - $21,389
1,662 Added 10.29%
17,816 $199,000
Q2 2018

Aug 13, 2018

BUY
$8.55 - $13.76 $17,544 - $28,235
2,052 Added 14.55%
16,154 $183,000
Q1 2018

May 14, 2018

SELL
$8.99 - $14.95 $20,955 - $34,848
-2,331 Reduced 14.18%
14,102 $130,000
Q4 2017

Feb 14, 2018

BUY
$8.26 - $16.76 $135,736 - $275,417
16,433
16,433 $244,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $377M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.